Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001789147-25-000008·MADRONE CAPITAL PARTNERS, LLC
Schedule 13G ownership disclosure
Pacific Biosciences of California Inc
Common Stock, par value $0.001 · CUSIP: 69404D108
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Madrone Capital Partners, LLC
Shares: 4,976,089.00 · Class: 1.7%
- Madrone Opportunity Fund, L.P.
Shares: 4,976,089.00 · Class: 1.7%
- Shimoda Holdings, LLC
Shares: 3,500,000.00 · Class: 1.2%
- Gregory Boyd Penner
Shares: 8,476,089.00 · Class: 2.8%
- Jameson J. McJunkin
Shares: 4,976,089.00 · Class: 1.7%
- Thomas Patterson
Shares: 4,976,089.00 · Class: 1.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001789147-25-000008
- Form type
- SCHEDULE 13G/A
- Filer
- MADRONE CAPITAL PARTNERS, LLC
- CIK
- CIK 1789147
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership